Early detection of bladder cancer in Yorkshire: Feasibility assessments for implementing a targeted study in populations with high disease specific mortality risk

People in Yorkshire will test their own urine at home for hidden blood, a possible early sign of bladder cancer, as part of a large feasibility study. Bladder cancer is often caught late, when treatment is less effective and survival rates are poor. Current diagnosis relies on people noticing blood in their urine and visiting a GP, but early-stage bleeding can be invisible. This project tests whether home dipstick testing—a cheap, simple method—can detect the disease earlier in high-risk groups. The researchers will run three parallel studies: 2,000 participants from an existing lung screening trial, 3,000 men randomly assigned to test for either blood or sugar (to see if the act of testing itself changes behaviour), and 500 NHS patients already referred for suspected bladder cancer. If the feasibility work shows that home testing is practical and acceptable, it could pave the way for a large-scale early detection programme. That would shift bladder cancer diagnosis from symptomatic, late-stage discovery to proactive, community-based screening—potentially catching tumours when they are smaller, less invasive, and far more treatable. The approach could also reduce pressure on NHS urology services by triaging patients more effectively.